简单无创血液检测预测HIV感染者脂肪性肝病肝硬度升高的诊断能力
本研究前瞻性纳入1065例接受抗逆转录病毒治疗的HIV感染者,评估FIB-4和NFS预测晚期纤维化(LSM≥11 kPa)的性能。FIB-4和NFS的AUC分别为0.70和0.75,阴性预测值高(97%-98%),但阳性预测值不佳。两者可用于筛查排除晚期纤维化,减少不必要的LSM或肝病转诊。
要点
- FIB-4和NFS对HIV感染者晚期纤维化有高阴性预测值(97%-98%),适合筛查排除。
- FIB-4低阈值敏感性64%、高阈值特异性97%;NFS低阈值敏感性80%、高阈值特异性96%。
- 两者阳性预测值不佳,不能用于确诊晚期纤维化。
核心结论
- FIB-4和NFS对HIV感染者晚期纤维化具有极好的特异性和阴性预测值,可作为筛查工具排除无需进一步LSM或肝病转诊的患者。
研究设计与样本
- 前瞻性收集两个美国国立卫生研究院资助的HIV NAFLD网络中的成人数据,共分析1065例接受抗逆转录病毒治疗≥6个月且HIV RNA<200 copies/mL的HIV感染者。
- 排除病毒性肝炎、其他肝病、过量饮酒或肝失代偿者,以振动控制瞬时弹性成像测定的LSM≥11 kPa定义晚期纤维化。
主要发现
- 参与者平均年龄51.6岁,74%男性,平均LSM为6.3 kPa,6.3%存在晚期纤维化。
- FIB-4和NFS识别晚期纤维化的AUC分别为0.70和0.75。
- FIB-4低阈值敏感性和高阈值特异性分别为64%和97%,NFS分别为80%和96%,两者阴性预测值均为97%-98%。
- FIB-4和NFS在任何阈值下阳性预测值均不佳。
关键数值与推荐
- FIB-4预设阈值:<1.3和>2.67;NFS预设阈值:<-1.455和>0.675。
- 晚期纤维化定义为LSM≥11 kPa。
临床怎么用
- 在HIV感染者中,可使用FIB-4或NFS作为初始筛查工具,低风险者(低于低阈值)可排除晚期纤维化,避免不必要的LSM或肝病转诊。
- 高风险者(高于高阈值)因阳性预测值不佳,仍需进一步LSM评估确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Steatotic liver disease is common in people with HIV (PWH). Identifying those with advanced fibrosis (AF, bridging fibrosis or cirrhosis), F3-4, is important. We aimed to examine the performance of FIB-4 and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) in PWH to identify those with AF assessed by liver stiffness measurement (LSM). METHODS: We prospectively collected data on adults participating in 2 National Institute of Health-sponsored HIV NAFLD networks. All had HIV on antiretroviral therapy (ART) ≥6 months with HIV RNA <200 copies/mL. Those with viral hepatitis, other liver disease, excessive alcohol use, or hepatic decompensation were excluded. Vibration-controlled transient elastrography for LSM was performed, and AF defined as ≥11 kPa was compared with FIB-4 and NFS at predefined thresholds (<1.3 and >2.67 for FIB-4 and <-1.455 and >0.675 for NFS). RESULTS: A total of 1,065 participants were analyzed: mean age 51.6 years, 74% male, 28% White, 46% Black, 22% Hispanic, with 34% overweight (body mass index 25-29 kg/m 2 ) and 43% obese (body mass index ≥30 kg/m 2 ). Features of the metabolic syndrome were common: hyperlipidemia 35%, type 2 diabetes 17%, and hypertension 48%. The median CD4 + T-cell count was 666 cells/mm 3 , 74% had undetectable HIV RNA, and duration of HIV-1 was 17 years with most taking a nucleoside reverse transcriptase inhibitor (92%) and an integrase inhibitor (83%). The mean LSM was 6.3 kPa, and 6.3% had AF. The area under the receiver characteristic curve for FIB-4 and NFS to identify AF were 0.70 and 0.75, respectively. While both had high negative predictive values (97%-98%), the sensitivity at low thresholds and specificity at high thresholds were 64% and 97% for FIB-4 and 80% and 96% for NFS, respectively. Neither FIB-4 nor NFS at either threshold had good positive predictive value to detect AF. DISCUSSION: FIB-4 and NFS have excellent specificity and negative predictive value for detecting AF, and thus can be used as screening tools in PWH to exclude those with AF who do not need further testing (LSM) or referral to hepatologist.
引用
- Sterling RK, Vilar-Gomez E, Wilson LA, et al. Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. Am J Gastroenterol. 2024. PMID: 38314810. doi:10.14309/ajg.0000000000002700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。